Canopy saw a significant decline in Canadian adult-use cannabis, where revenue fell 24% to C$18.4 million. This offset the 16% gain from Canadian medical cannabis which reached C$18.7 million, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback